Sensitive bioluminescence imaging of cryptococcosis in Galleria mellonella improves antifungal screening under in vivo conditions

ABSTRACTCryptococcus neoformans is an environmental yeast that primarily affects immunocompromised individuals, causing respiratory infections and life-threatening meningoencephalitis. Treatment is complicated by limited antifungal options, with concerns such as adverse effects, dose-limiting toxici...

Full description

Bibliographic Details
Main Authors: Eliane Vanhoffelen, Lori Vermoesen, Lauren Michiels, Katrien Lagrou, Agustin Reséndiz-Sharpe, Greetje Vande Velde
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Virulence
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/21505594.2024.2327883
_version_ 1797263212059557888
author Eliane Vanhoffelen
Lori Vermoesen
Lauren Michiels
Katrien Lagrou
Agustin Reséndiz-Sharpe
Greetje Vande Velde
author_facet Eliane Vanhoffelen
Lori Vermoesen
Lauren Michiels
Katrien Lagrou
Agustin Reséndiz-Sharpe
Greetje Vande Velde
author_sort Eliane Vanhoffelen
collection DOAJ
description ABSTRACTCryptococcus neoformans is an environmental yeast that primarily affects immunocompromised individuals, causing respiratory infections and life-threatening meningoencephalitis. Treatment is complicated by limited antifungal options, with concerns such as adverse effects, dose-limiting toxicity, blood–brain barrier permeability, and resistance development, emphasizing the critical need to optimize and expand current treatment options against invasive cryptococcosis. Galleria mellonella larvae have been introduced as an ethical intermediate for in vivo testing, bridging the gap between in vitro antifungal screening and mouse studies. However, current infection readouts in G. mellonella are indirect, insensitive, or invasive, which hampers the full potential of the model. To address the absence of a reliable non-invasive method for tracking infection, we longitudinally quantified the cryptococcal burden in G. mellonella using bioluminescence imaging (BLI). After infection with firefly luciferase-expressing C. neoformans, the resulting bioluminescence signal was quantitatively validated using colony-forming unit analysis. Longitudinal comparison of BLI to health and survival analysis revealed increased sensitivity of BLI in discriminating cryptococcal burden during early infection. Furthermore, BLI improved the detection of treatment efficacy using first-line antifungals, thereby benchmarking this model for antifungal testing. In conclusion, we introduced BLI as a real-time, quantitative readout of cryptococcal burden in G. mellonella over time, enabling more sensitive and reliable antifungal screening.
first_indexed 2024-04-25T00:09:25Z
format Article
id doaj.art-b610f3738b4c4b41b80c060fe02c5b10
institution Directory Open Access Journal
issn 2150-5594
2150-5608
language English
last_indexed 2024-04-25T00:09:25Z
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series Virulence
spelling doaj.art-b610f3738b4c4b41b80c060fe02c5b102024-03-13T15:36:02ZengTaylor & Francis GroupVirulence2150-55942150-56082024-12-0115110.1080/21505594.2024.2327883Sensitive bioluminescence imaging of cryptococcosis in Galleria mellonella improves antifungal screening under in vivo conditionsEliane Vanhoffelen0Lori Vermoesen1Lauren Michiels2Katrien Lagrou3Agustin Reséndiz-Sharpe4Greetje Vande Velde5Department of Imaging and Pathology, Biomedical MRI unit/MoSAIC, KU Leuven, Leuven, BelgiumDepartment of Imaging and Pathology, Biomedical MRI unit/MoSAIC, KU Leuven, Leuven, BelgiumDepartment of Imaging and Pathology, Biomedical MRI unit/MoSAIC, KU Leuven, Leuven, BelgiumDepartment of Microbiology, Immunology and Transplantation, Laboratory of Clinical Microbiology, KU Leuven, Leuven, BelgiumDepartment of Imaging and Pathology, Biomedical MRI unit/MoSAIC, KU Leuven, Leuven, BelgiumDepartment of Imaging and Pathology, Biomedical MRI unit/MoSAIC, KU Leuven, Leuven, BelgiumABSTRACTCryptococcus neoformans is an environmental yeast that primarily affects immunocompromised individuals, causing respiratory infections and life-threatening meningoencephalitis. Treatment is complicated by limited antifungal options, with concerns such as adverse effects, dose-limiting toxicity, blood–brain barrier permeability, and resistance development, emphasizing the critical need to optimize and expand current treatment options against invasive cryptococcosis. Galleria mellonella larvae have been introduced as an ethical intermediate for in vivo testing, bridging the gap between in vitro antifungal screening and mouse studies. However, current infection readouts in G. mellonella are indirect, insensitive, or invasive, which hampers the full potential of the model. To address the absence of a reliable non-invasive method for tracking infection, we longitudinally quantified the cryptococcal burden in G. mellonella using bioluminescence imaging (BLI). After infection with firefly luciferase-expressing C. neoformans, the resulting bioluminescence signal was quantitatively validated using colony-forming unit analysis. Longitudinal comparison of BLI to health and survival analysis revealed increased sensitivity of BLI in discriminating cryptococcal burden during early infection. Furthermore, BLI improved the detection of treatment efficacy using first-line antifungals, thereby benchmarking this model for antifungal testing. In conclusion, we introduced BLI as a real-time, quantitative readout of cryptococcal burden in G. mellonella over time, enabling more sensitive and reliable antifungal screening.https://www.tandfonline.com/doi/10.1080/21505594.2024.2327883Galleria mellonellacryptococcus neoformansantifungal screeningbioluminescence imagingcryptococcosisfungal infection
spellingShingle Eliane Vanhoffelen
Lori Vermoesen
Lauren Michiels
Katrien Lagrou
Agustin Reséndiz-Sharpe
Greetje Vande Velde
Sensitive bioluminescence imaging of cryptococcosis in Galleria mellonella improves antifungal screening under in vivo conditions
Virulence
Galleria mellonella
cryptococcus neoformans
antifungal screening
bioluminescence imaging
cryptococcosis
fungal infection
title Sensitive bioluminescence imaging of cryptococcosis in Galleria mellonella improves antifungal screening under in vivo conditions
title_full Sensitive bioluminescence imaging of cryptococcosis in Galleria mellonella improves antifungal screening under in vivo conditions
title_fullStr Sensitive bioluminescence imaging of cryptococcosis in Galleria mellonella improves antifungal screening under in vivo conditions
title_full_unstemmed Sensitive bioluminescence imaging of cryptococcosis in Galleria mellonella improves antifungal screening under in vivo conditions
title_short Sensitive bioluminescence imaging of cryptococcosis in Galleria mellonella improves antifungal screening under in vivo conditions
title_sort sensitive bioluminescence imaging of cryptococcosis in galleria mellonella improves antifungal screening under in vivo conditions
topic Galleria mellonella
cryptococcus neoformans
antifungal screening
bioluminescence imaging
cryptococcosis
fungal infection
url https://www.tandfonline.com/doi/10.1080/21505594.2024.2327883
work_keys_str_mv AT elianevanhoffelen sensitivebioluminescenceimagingofcryptococcosisingalleriamellonellaimprovesantifungalscreeningunderinvivoconditions
AT lorivermoesen sensitivebioluminescenceimagingofcryptococcosisingalleriamellonellaimprovesantifungalscreeningunderinvivoconditions
AT laurenmichiels sensitivebioluminescenceimagingofcryptococcosisingalleriamellonellaimprovesantifungalscreeningunderinvivoconditions
AT katrienlagrou sensitivebioluminescenceimagingofcryptococcosisingalleriamellonellaimprovesantifungalscreeningunderinvivoconditions
AT agustinresendizsharpe sensitivebioluminescenceimagingofcryptococcosisingalleriamellonellaimprovesantifungalscreeningunderinvivoconditions
AT greetjevandevelde sensitivebioluminescenceimagingofcryptococcosisingalleriamellonellaimprovesantifungalscreeningunderinvivoconditions